<DOC>
	<DOC>NCT00953680</DOC>
	<brief_summary>This study will evaluate the bioequivalence of the losartan/hydrochlorothiazide (HCTZ) combination tablet and coadministration of losartan and hydrochlorothiazide.</brief_summary>
	<brief_title>Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)</brief_title>
	<detailed_description />
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Subject is a healthy male or female between the ages of 18 and 45 years of age Subject does not smoke Subject has a history of any illness that might pose additional risk to participation or confound the results of the study Subject has a history of hepatitis B or C or significant drug allergies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>